ScholarLens Back to search
2011•Nurse PrescribingRequires access

Oral anticoagulants in the management of thromboembolism

Kate Woodrow, Nicola Korn

Open publisher page 1 citations

Abstract

Venous thromboembolism presents a major public health concern in the UK, and increases morbidity and mortality in hospitalized patients. With the development of two new classes of oral anticoagulants, direct thrombin inhibitors (dabigatran) and direct factor Xa inhibitors (rivaroxaban), there could be a paradigm shift in the management of acute venous thromboembolism.

About this research paper

What this paper is about

Venous thromboembolism presents a major public health concern in the UK, and increases morbidity and mortality in hospitalized patients. With the development of two new classes of oral anticoagulants, direct thrombin inhibitors (dabigatran) and direct factor Xa inhibitors (rivaroxaban), there could be a paradigm shift in the management of acute venous thromboembolism.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Venous thromboembolism presents a major public health concern in the UK, and increases morbidity and mortality in hospitalized patients. With the development of two new classes of oral anticoagulants, direct thrombin inhibitors (dabigatran) and direct factor Xa inhibitors (rivaroxaban), there could be a paradigm shift in the management of acute venous thromboembolism.

Key concepts: Medicine, Rivaroxaban, Dabigatran, Venous thromboembolism, Intensive care medicine, Discovery and development of direct thrombin inhibitors, Direct thrombin inhibitor, Thrombin

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Oral anticoagulants in the management of thromboembolism — Research Paper | ScholarLens